Goss Wealth Management »

Bioline Rx shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Bioline Rx (BLRX) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Bioline Rx

Tip: Access up to 7 years of quarterly data

All positions including Bioline Rx held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioline Rx by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $404 107 3.79
2025-06-30 $489 107 4.57
2025-03-31 $316 107 2.96

More positions owned by Goss Wealth Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Ishares Core MF Closed and MF Open (IVV)
SPDR S&P MF Closed and MF Open (SPY)
Vanguard S&p MF Closed and MF Open (VOO)
Broadcom Common Stock (AVGO)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Ishares U S MF Closed and MF Open (DYNF)
Ishares Msci MF Closed and MF Open (QUAL)
Ishares S&p MF Closed and MF Open (IVW)
Vanguard Value MF Closed and MF Open (VTV)
Vanguard Growth MF Closed and MF Open (VUG)
Meta Platforms Common Stock (META)

View all positions for Goss Wealth Management

Top funds holding Bioline Rx

Susquehanna International
Citadel Advisors
UBS Group
Rhumbline Advisers
Wells Fargo & Company
Nemes Rush Group
Goss Wealth Management
Simplex Trading
Tower Research Capital
Rockefeller Capital Management
SBI Securities
Danske Bank A/s
Advisor Group Holdings

View all funds holding Bioline Rx